Netherlands
5 papers8 directions
The Netherlands serves as a research venue for studies at the intersection of artificial intelligence and clinical medicine, with a primary focus on cardiovascular applications. Active between 2006 and 2019, the venue features contributions from researchers such as Tim Leiner, Derek P. Chew, and Leonard Hofstra. The research often explores the implementation of AI in general cardiology and cardiovascular imaging, examining how these technologies can be integrated into standard medical practice and diagnostic workflows.
Research published in this context frequently utilizes statistical methodologies such as mixed effects models for longitudinal and nested data, as well as proportional hazards regression for clinical survival analysis. Key research directions include the longitudinal analysis of real-world clinical outcomes and the study of temporal precision within therapeutic windows. A significant portion of the work addresses the gap between clinical innovation and economic accessibility, evaluating how advanced diagnostic tools and AI-driven insights impact patient care and healthcare systems.
While the venue is heavily weighted toward medical AI, it also encompasses interdisciplinary contributions, such as legal research regarding the inclusion of extremist speech. Its role in the machine learning community is characterized by the application of predictive modeling and automated imaging analysis to specialized medical fields. By comparing clinical outcomes across different regions and demographics, the research contributes to understanding the influence of age, ethnicity, and technological intervention on long-term health outcomes.
Papers by Year
| 2019 | 2 |
| 2016 | 2 |
| 2006 | 1 |
Top Research Directions
Research directions most represented by papers from this venue.
Impactful Papers
Papers from this venue that shaped research clusters.
Influential
Artificial intelligence in cardiovascular imaging: state of the art and implications for the imaging
influential
Privacy Preserving Frameworks for Clinic
2019
Treatment of pulmonary arterial hypertension in congenital heart disease in Singapore versus the Net
influential
Proportional Hazards Modeling for Surviv
2016
Treatment of pulmonary arterial hypertension in congenital heart disease in Singapore versus the Net
influential
Evaluating Clinical Outcomes Using Histo
2016